Oklahoma faces off in court against Johnson & Johnson in the first major case against an opioid maker to go to trial.
Oklahoma faces off in court against Johnson & Johnson on Tuesday, marking the first major case against an opioid maker to go to trial.
The other defendants in the suit have settled with the state, including Israeli-based Teva Pharmaceuticals, which agreed to pay $85 million on Sunday and OxyContin maker Purdue Pharma, which settled for $270 million in March. On Sunday, Hunter said the Teva settlement was a testament to the state’s legal team’s"countless hours and resources preparing for this trial and their dedication and resolve to hold the defendants in this case accountable for the ongoing opioid overdose and addiction epidemic that continues to claim thousands of lives each year."
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
First Big Trial in Opioid Crisis Set to Kick Off in OklahomaIn a trial starting Tuesday, lawyers for Oklahoma Attorney General Mike Hunter will argue that the marketing practices of Johnson & Johnson played a role in fueling the opioid epidemic
Baca lebih lajut »
Spotlight on Oklahoma for start of trial for opioid makersOKLAHOMA CITY (AP) — Oklahoma is poised to become the first state to go to trial in a lawsuit against the makers of pharmaceuticals blamed for contributing to the nation's opioid crisis.
Baca lebih lajut »
Oklahoma takes on drugmakers J&J, Teva in landmark opioid trialOklahoma’s $17 billion lawsuit against opioid makers Johnson & Johnson and Teva is the first to go to trial of more than 2,000 similar actions by state and local governments
Baca lebih lajut »
Johnson & Johnson loses $25-million verdict in a baby powder cancer caseThis is the 10th win for talc plaintiffs since trials over cancer claims tied to Johnson & Johnson’s talc-based powders began in 2016. J&J has won six.
Baca lebih lajut »
Historic trial tests whether big pharma can be held accountable for opioid epidemicThe Oklahoma trial is the first major trial of nearly 2,000 cases around the country in which states, cities and hard-hit local municipalities are seeking to hold opioid makers accountable for the epidemic that has left hundreds of thousands of Americans dead, and strapped resources in every state.
Baca lebih lajut »
Oklahoma, Teva Pharmaceuticals reach $85 million settlement in opioid caseThe Israel-based company admitted no wrongdoing and denies a role in the deadly crisis.
Baca lebih lajut »
Teva Settles Oklahoma Opioid Case for $85 MillionTeva's $85 million settlement with Oklahoma comes days before the company was set to defend itself at a landmark trial amid some 2,000 lawsuits brought by states and local municipalities against pharmaceutical companies over the opioid crisis
Baca lebih lajut »
Teva Pharm to pay Oklahoma $85 million to settle opioid claimsTeva Pharmaceutical Industries Ltd said on Sunday it had agreed to pay an $85 mi...
Baca lebih lajut »
Drugmaker Teva to pay $85 million to settle Oklahoma opioid lawsuitTeva Pharmaceuticals, one of the biggest makers of generic drugs, has agreed to pay $85 million to settle a lawsuit brought by the Oklahoma attorney general over allegations that the company contributed to the state's opioid painkiller epidemic.
Baca lebih lajut »
Oklahoma reaches $85 million settlement with Teva Pharmaceuticals ahead of trialOklahoma has reached a $85 million settlement agreement with Israeli-based Teva ...
Baca lebih lajut »
Who is Boris Johnson, the man poised to be the next British leader?A disheveled, divisive populist, Johnson is the bookmakers' favorite to take over as leader of the ruling Conservative Party.
Baca lebih lajut »